LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 22.76 | 17.25 | 1567 | 1193 | 1.3129 | 1.0911 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 24.73 | 17.25 | 19 | 1290 | 0.0147 | 0.0156 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 24.73 | 17.25 | 1682 | 1290 | 1.3037 | 1.0870 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 24.73 | 17.25 | 29 | 1290 | 0.0225 | 0.0870 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 24.73 | 17.25 | 1693 | 1290 | 1.3122 | 1.0892 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 26.70 | 17.25 | 24 | 1466 | 0.0164 | 0.0529 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 26.70 | 17.25 | 1834 | 1466 | 1.2504 | 1.0710 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 26.70 | 17.25 | 24 | 1466 | 0.0164 | 0.0529 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 26.70 | 17.25 | 1819 | 1466 | 1.2402 | 1.0683 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 28.67 | 17.25 | 19 | 1653 | 0.0115 | 0.0148 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 28.67 | 17.25 | 2048 | 1653 | 1.2389 | 1.0661 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 28.67 | 17.25 | 26 | 1653 | 0.0157 | 0.0643 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 28.67 | 17.25 | 2049 | 1653 | 1.2395 | 1.0663 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 30.64 | 17.25 | 33 | 1887 | 0.0175 | 0.1005 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 30.64 | 17.25 | 2278 | 1887 | 1.2069 | 1.0563 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 30.64 | 17.25 | 33 | 1887 | 0.0175 | 0.1005 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 30.64 | 17.25 | 2309 | 1887 | 1.2234 | 1.0604 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 32.61 | 17.25 | 31 | 2136 | 0.0145 | 0.0880 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 32.61 | 17.25 | 2495 | 2136 | 1.1679 | 1.0451 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 32.61 | 17.25 | 31 | 2136 | 0.0145 | 0.0880 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 32.61 | 17.25 | 2505 | 2136 | 1.1726 | 1.0463 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 34.57 | 17.25 | 12 | 2523 | 0.0048 | -0.0492 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 34.57 | 17.25 | 2713 | 2523 | 1.0752 | 1.0203 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 34.57 | 17.25 | 37 | 2523 | 0.0147 | 0.1119 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 34.57 | 17.25 | 2783 | 2523 | 1.1030 | 1.0274 | MN20160310_N02 | E21 |